Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Pharvaris BV

9EN
Current price
18.6 EUR +0.5 EUR (+2.76%)
Last closed 20.55 USD
ISIN NL00150005Y4
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 1 221 114 112 USD
Yield for 12 month +30.37 %
1Y
3Y
5Y
10Y
15Y
9EN
21.11.2021 - 28.11.2021

Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. The company operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands. Address: Emmy Noetherweg 2, Leiden, Netherlands, 2333 BK

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

34.59 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-268 870 USD

Last Year

-160 068 USD

Current Quarter

-73 566 USD

Last Quarter

-71 137 USD

Key Figures 9EN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -116 103 928 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -26.79 %
PEG Ratio
Return On Equity TTM -45.05 %
Wall Street Target Price 34.59 USD
Revenue TTM
Book Value 6.16 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.8 USD
Diluted Eps TTM -2.8 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 9EN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 9EN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 9EN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -1.3794
Price Book MRQ 3.4195

Financials 9EN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 9EN

For 52 weeks

15 USD 33 USD
50 Day MA 20.54 USD
Shares Short Prior Month 813 008
200 Day MA 21.14 USD
Short Ratio 1.2
Shares Short 131 765
Short Percent 0.32 %